The effect of Chinese herbs and its effective components on coronary heart disease through PPARs-PGC1α pathway

BMC Complementary and Alternative Medicine

Research Article

Chun Li¹  Yi Zhang¹  Yuanyuan Wang²  Linghui Lu²  Tianjiao Shi²  Qiyan Wang³  Yong Wang⁴  Wei Wang⁴  Qian Zhang⁴ 

[1] Modern Research Center for Traditional Chinese Medicine,School of Chinese Materia Medica, Beijing University of Chinese Medicine, 100102, Beijing, China;School of Basic Medical Science, Beijing University of Chinese Medicine, 100029, Beijing, China;School of Life Sciences, Beijing University of Chinese Medicine, 100029, Beijing, China;School of Life Sciences, Beijing University of Chinese Medicine, 100029, Beijing, China;School of Basic Medical Science, Beijing University of Chinese Medicine, 100029, Beijing, China;

关键词: Components;    Coronary heart disease;    PPARs-PGC1α pathway;    DanQi pill;   

DOI  :  10.1186/s12906-016-1496-z

 received in 2016-06-08, accepted in 2016-12-05,  发布年份 2016

来源: Springer

【 摘 要 】

BackgroundDanQi pill (DQP) is prescribed widely in China and has definite cardioprotective effect on coronary heart disease. Our previous studies proved that DQP could effectively regulate plasma levels of high density lipoprotein (HDL) and low density lipoprotein (LDL). However, the regulatory mechanisms of DQP and its major components Salvianolic acids and Panax notoginseng saponins (DS) on lipid metabolism disorders haven’t been comprehensively studied so far.MethodsRat model of coronary heart disease was induced by left anterior descending (LAD) artery ligation operations. Rats were divided into sham, model, DQP treated, DS treated and positive drug (clofibrate) treated groups. At 28 days after surgery, cardiac functions were assessed by echocardiography. Expressions of transcription factors and key molecules in energy metabolism pathway were measured by reverse transcriptase polymerase chain reaction or western blotting.ResultsIn ischemic heart model, cardiac functions were severely injured but improved by treatments of DQP and DS. Expression of LPL was down-regulated in model group. Both DQP and DS could up-regulate the mRNA expression of LPL. Membrane proteins involved in lipid transport and uptake, such as FABP4 and CPT-1A, were down-regulated in ischemic heart tissues. Treatment with DQP and DS regulated lipid metabolisms by up-regulating expressions of FABP4 and CPT-1A. DQP and DS also suppressed expression of cytochrome P450. Furthermore, transcriptional factors, such as PPARα, PPARγ, RXRA and PGC-1α, were down-regulated in ischemic model group. DQP and DS could up-regulate expressions of these factors. However, DS showed a better efficacy than DQP on PGC-1α, a coactivator of PPARs. Key molecules in signaling pathways such as AKT1/2, ERK and PI3K were also regulated by DQP and DS simultaneously.ConclusionsSalvianolic acids and Panax notoginseng are the major effective components of DanQi pill in improving lipid metabolism in ischemic heart model. The effects may be mediated by regulating transcriptional factors such as PPARs, RXRA and PGC-1α.

【 授权许可】

CC BY   
© The Author(s). 2016